| Symbol | Name | Grade | Market Cap | Country |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | 73.2 | ¤796,273 | US |
| NOVO.B.DK | Novo Nordisk A/S Class B | 77.1 | ¤285,495 | DK |
| MRK | Merck & Co., Inc. | 72.5 | ¤196,278 | US |
| ISRG | Intuitive Surgical, Inc. | 62.1 | ¤172,954 | US |
| AMGN | Amgen Inc. | 54.2 | ¤149,085 | US |
| Symbol | Name | Grade | Market Cap | Country |
|---|---|---|---|---|
| HLUN.B.DK | H. Lundbeck A/S Class B | 61.1 | ¤4,322 | DK |
| SFZN.CH | Siegfried Holding AG | 58.0 | ¤4,754 | CH |
| ALK.B.DK | ALK-abello A/S Class B | 70.8 | ¤5,023 | DK |
| SRPT | Sarepta Therapeutics, Inc. | 63.2 | ¤5,219 | US |
| 326030.KR | SK Biopharmaceuticals Co., Ltd. | 73.8 | ¤5,786 | KR |
| Symbol | Name | Grade | Times* | Country |
|---|---|---|---|---|
| NOVO.B.DK | Novo Nordisk A/S Class B | 77.1 | 36 | DK |
| BIIB | Biogen Inc. | 57.1 | 30 | US |
| AMGN | Amgen Inc. | 54.2 | 29 | US |
| ISRG | Intuitive Surgical, Inc. | 62.1 | 25 | US |
| REGN | Regeneron Pharmaceuticals, Inc. | 62.3 | 23 | US |
| RMD | ResMed Inc. | 69.1 | 23 | US |
| EW | Edwards Lifesciences Corporation | 47.6 | 22 | US |
| LLY | Eli Lilly and Company | 73.2 | 21 | US |
| 4507.JP | Shionogi & Co., Ltd. | 67.5 | 20 | JP |
| 4519.JP | Chugai Pharmaceutical Co., Ltd. | 68.5 | 19 | JP |
| Average Market Cap | ¤54,550 |
| Median Market Cap | ¤12,916 |
| Avg. 3 Mo. Dollar Vol. | ¤328,312,601 |
| Avg. 3 Mo. Trading Vol. | 3,424,709 |
| Last Rebalance Date | 03/24/2025 |
| Companies Replaced | 16 |
| Biggest Industry Increase | Pharmaceuticals: Major |
| Biggest Industry Decrease | Medical Specialties |
| Trailing P/E Ratio (12 Mo.) | 23.2 |
| Forward P/E Ratio (12 Mo.) | 19.0 |
| Price/Book Ratio | 4.3 |
| Avg. Revenue Chg. - 3 Yr | 41.4% |
| Avg. Op. Income Chg. - 3 Yr. | 38.4% |
| Avg. EPS Growth - 3 Yr. | 12.2% |
| Avg. EPS Growth - 1 Yr. | 12.2% |
| Avg. Operating Margin | 22.4% |
| Avg. LT Debt to Total Capital | 33.3% |
| Avg. Return on Equity | 20.6% |
| Dividend Yield | 0% |
| Developed Markets (ex-Australia) Health Care Index | 62.41 |
| United States Of America | 68.0% |
| Japan | 12.0% |
| Denmark | 8.0% |
| Korea, Republic Of | 4.0% |
| Sweden | 2.0% |
| Finland | 2.0% |
| Ireland | 2.0% |
| Switzerland | 2.0% |
